Estudios estadísticos presentación clínica y complicaciones de hiperplasia prostática benigna en pacientes de 50 a 70 años
Fecha
2018
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Medicina
Resumen
Introducción: La hiperplasia prostática benigna (HPB) es un problema común entre los hombres mayores y es responsable de una discapacidad considerable. La prevalencia de HBP diagnosticada histológicamente aumenta del 8 por ciento en hombres de 31 a 40 años, del 40 al 50 por ciento en hombres de 51 a 60 años, a más del 80 por ciento en hombres mayores de 80 años.
Metodología: Demostrar la incidencia de pacientes con hiperplasia prostática benigna y sus complicaciones en pacientes atendidos en el Hospital León Becerra de Milagro mediante estudios de laboratorio y estadificación clínica. Se estableció un estudio retrospectivo, observacional y descriptivo durante el año 2016 - 2017, el universo escogido fueron pacientes atendidos en el área de Cirugía General y Urología. el tamaño de la muestra fueron 86 pacientes que presentaron complicaciones en su evolución de enfermedad se estableció un Nivel de Confianza del 95% con un margen de error de 5.
Resultados: Se demostrando mayor incidencia en pacientes con 70 años o menos este grupo presentó 53 pacientes representando el 61,6% del total, Según la clasificación en el I-PSS score el 9,3% de pacientes presentaron una clasificación de tipo LEVE, el 31,4% presentaron una clasificación moderada y el 59,3% del total presentaron síntomas de forma SEVERA. El tratamiento
XV
médico puede ser llevada de cuatro modalidades la cual es la terapia androgénica, los bloqueantes alfa, el tratamiento combinado y la fitoterapia.
Introduction: Benign prostatic hyperplasia (BPH) is a common problem among older men and is responsible for considerable disability. The prevalence of histologically diagnosed BPH increases from 8 percent in men from 31 to 40 years, from 40 to 50 percent in men from 51 to 60 years, to more than 80 percent in men over 80 years. Methodology: To demonstrate the incidence of patients with benign prostatic hyperplasia and its complications in patients treated at the León Becerra de Milagro Hospital through laboratory studies and clinical staging. A retrospective, observational and descriptive study was established during the year 2016 - 2017, the chosen universe were patients attended in the area of General Surgery and Urology. The sample size was 86 patients who presented complications in their evolution of disease, a Confidence Level of 95% was established with a margin of error of 5. Results: A greater incidence was demonstrated in patients with 70 years or less. This group presented 53 patients representing 61.6% of the total. According to the classification in the I-PSS score, 9.3% of patients presented a classification of LEVE type, 31.4% presented a moderate classification and 59.3% of the total XVII presented symptoms of a SEVERE form. Medical treatment can be carried out in four modalities which is androgenic therapy, alpha blockers, combined treatment and phytotherapy.
Introduction: Benign prostatic hyperplasia (BPH) is a common problem among older men and is responsible for considerable disability. The prevalence of histologically diagnosed BPH increases from 8 percent in men from 31 to 40 years, from 40 to 50 percent in men from 51 to 60 years, to more than 80 percent in men over 80 years. Methodology: To demonstrate the incidence of patients with benign prostatic hyperplasia and its complications in patients treated at the León Becerra de Milagro Hospital through laboratory studies and clinical staging. A retrospective, observational and descriptive study was established during the year 2016 - 2017, the chosen universe were patients attended in the area of General Surgery and Urology. The sample size was 86 patients who presented complications in their evolution of disease, a Confidence Level of 95% was established with a margin of error of 5. Results: A greater incidence was demonstrated in patients with 70 years or less. This group presented 53 patients representing 61.6% of the total. According to the classification in the I-PSS score, 9.3% of patients presented a classification of LEVE type, 31.4% presented a moderate classification and 59.3% of the total XVII presented symptoms of a SEVERE form. Medical treatment can be carried out in four modalities which is androgenic therapy, alpha blockers, combined treatment and phytotherapy.
Descripción
PDF
Palabras clave
HIPERPLASIA PROSTATICA, UROPATIA OBSTRUCTIVA, ANTIGENO PROSTATICO, ESTUDIOS RETROSPECTIVOS, HOSPITAL GENERAL DR. LEON BECERRA CAMACHO, CANTON MILAGRO, ECUADOR, INDICADORES (ESTADISTICA)